16-18 Mai 2022
\nMilan, Italie<\/p>\n
Â鶹Æƽâ°æ participera \u00e0 la 22e \u00e9dition de Bio\u20acquity Europe, l\u2019\u00e9v\u00e8nement international en Europe pour les investisseurs et les dirigeants de l\u2019industrie biopharmaceutique, qui y rencontreront des entreprises de biotechnologie en plein essor.
\nL\u2019\u00e9quipe d\u2019Â鶹Æƽâ°æ reprend contact avec les investisseurs et partenaires potentiels afin d\u2019acc\u00e9l\u00e9rer le d\u00e9veloppement clinique de son compos\u00e9 principal Vonafexor ax\u00e9 sur les maladies r\u00e9nales et h\u00e9patiques. Jacky Vonderscher pr\u00e9sentera \u00e9galement \u201cVONAFEXOR, a fibrolytic and anti-inflammatory for the treatment of kidney and liver diseases\u201d lors de la session Hot Topics Track #1, 16h30-16h42, le 17 mai 2022<\/p>\n
https:\/\/conferences.biocentury.com\/bioequity-europe<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" 16-18 Mai 2022 Â鶹Æƽâ°æ participera \u00e0 la 22e \u00e9dition de Bio\u20acquity Europe, l\u2019\u00e9v\u00e8nement international en Europe pour les investisseurs et les dirigeants de l\u2019industrie biopharmaceutique, qui y rencontreront des entreprises de biotechnologie en plein essor. Lire la suite »<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[12],"tags":[],"class_list":["post-4110","post","type-post","status-publish","format-standard","hentry","category-events-fr"],"acf":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"","rttpg_featured_image_url":null,"rttpg_author":{"display_name":"editorENYOPharma","author_link":"https:\/\/www.enyopharma.com\/fr\/author\/editorenyopharma\/"},"rttpg_comment":0,"rttpg_category":"\u00c9v\u00e9nements<\/a>","rttpg_excerpt":"16-18 Mai 2022 Milan, Italie Â鶹Æƽâ°æ participera \u00e0 la 22e \u00e9dition de Bio\u20acquity Europe, l\u2019\u00e9v\u00e8nement international en Europe pour les investisseurs et les dirigeants de l\u2019industrie biopharmaceutique, qui y rencontreront des entreprises de biotechnologie en plein essor. L\u2019\u00e9quipe d\u2019Â鶹Æƽâ°æ reprend contact avec les investisseurs et partenaires potentiels afin d\u2019acc\u00e9l\u00e9rer le d\u00e9veloppement clinique de…","_links":{"self":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/4110","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/comments?post=4110"}],"version-history":[{"count":2,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/4110\/revisions"}],"predecessor-version":[{"id":4112,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/posts\/4110\/revisions\/4112"}],"wp:attachment":[{"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/media?parent=4110"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/categories?post=4110"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.enyopharma.com\/fr\/wp-json\/wp\/v2\/tags?post=4110"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nMilan, Italie<\/p>\n
\nL\u2019\u00e9quipe d\u2019Â鶹Æƽâ°æ reprend contact avec les investisseurs et partenaires potentiels afin d\u2019acc\u00e9l\u00e9rer le d\u00e9veloppement clinique de son compos\u00e9 principal Vonafexor ax\u00e9 sur les maladies r\u00e9nales et h\u00e9patiques. Jacky Vonderscher pr\u00e9sentera \u00e9galement \u201cVONAFEXOR,<\/p>\n